LAMP1 and Marburg hemorrhagic fever: In this study, we constructed a novel MARV DNA vaccine fused with LAMP1 and demonstrated that the LAMP targeting strategy significantly improved the immunogenicity of the candidate vaccine and improved humoral and cellular immune effects in immunized mice, providing a potentially effective candidate vaccine for preventing and controlling MHF epidemics.